Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
4.200
+0.160 (3.96%)
At close: Apr 28, 2026, 4:00 PM EDT
4.410
+0.210 (5.00%)
Pre-market: Apr 29, 2026, 4:57 AM EDT
Ironwood Pharmaceuticals Employees
Ironwood Pharmaceuticals had 100 employees as of December 31, 2025. The number of employees decreased by 153 or -60.47% compared to the previous year.
Employees
100
Change (1Y)
-153
Growth (1Y)
-60.47%
Revenue / Employee
$2,961,510
Profits / Employee
$240,170
Market Cap
684.84M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 1,976 |
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Kamada | 462 |
| Esperion Therapeutics | 294 |
IRWD News
- 5 days ago - Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026 - Business Wire
- 6 weeks ago - Ironwood Pharmaceuticals Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference - Business Wire
- 2 months ago - Ironwood Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook - Business Wire
- 2 months ago - Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call - Business Wire
- 4 months ago - Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance - Business Wire
- 6 months ago - Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance - Business Wire